TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2023 Earnings Call Transcript May 1, 2023
TG Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.28, expectations were $-0.37.
Operator: Greetings, and welcome to the TG Therapeutics First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It would now like to turn the call over to Jenna...
